78 results
Page 2 of 4
8-K
EX-99.1
dv1phnzh 7ezr
18 May 22
Acasti Pharma Announces Positive Results for Pharmacokinetic Bridging Study, with Intravenous GTX-104 Meeting All Endpoints
7:37am
8-K
xc58thk2v 2t4
25 Mar 22
Acasti Pharma Appoints Healthcare Industry Leader Michael L. Derby to its Board of Directors
7:36am
8-K
EX-99.1
fvmi451pkpk1289mtb
2 Dec 21
Acasti Pharma Announces Interim Data Meets All Primary Endpoints for Pivotal PK Study for GTX-104
7:17am
424B5
6vk6zi
10 Nov 21
Prospectus supplement for primary offering
7:23am
425
r6fvt5vckogafm9n18
4 Aug 21
Business combination disclosure
5:03pm
8-K
EX-99.1
br9j 0eajfik3rmyv
21 Jul 21
Other Events
5:17pm
425
EX-99.1
d23xn 2nvt9hv4a
21 Jul 21
Business combination disclosure
5:15pm
424B3
t2bv3bufm
15 Jul 21
Prospectus supplement
4:45pm
S-4/A
jnpu5f1djcdi4r 5hk
13 Jul 21
Registration of securities issued in business combination transactions (amended)
4:41pm
S-4
EX-10.12
h0xg405zr52
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
S-4
91k vjpz1kfhvp
1 Jul 21
Registration of securities issued in business combination transactions
12:00am